Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-24 @ 6:59 PM
NCT ID:
NCT00462657
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* At high risk for developing invasive aspergillosis (IA) due to any of the following risk factors:
* Diagnosis of acute myeloid leukemia, myelodysplastic syndromes, or acute lymphoblastic leukemia AND meets ≥ 1 of the following criteria:
* Receiving intensive chemotherapy with expected duration of neutropenia (ANC \< 500/mm³) of \> 10 days
* Receiving high-dose steroids
* Concurrent treatment with allogeneic hematopoietic stem cell transplantation (HSCT)
* Requirement for high-dose steroids for graft-versus-host disease after HSCT
* History of probable or proven IA and receiving chemotherapy
* No preexisting chest disease
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00462657
Study Brief:
Protocol Section:
NCT00462657